Global and United States General Anxiety Disorder Therapeutics Market Report & Forecast 2024-2031

Report ID: 1838765 | Published Date: Sep 2024 | No. of Page: 70 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 General Anxiety Disorder Therapeutics Revenue in General Anxiety Disorder Therapeutics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global General Anxiety Disorder Therapeutics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global General Anxiety Disorder Therapeutics Market Size for the Year 2017-2028
        1.2.2 Global General Anxiety Disorder Therapeutics Market Size for the Year 2017-2028
    1.3 General Anxiety Disorder Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States General Anxiety Disorder Therapeutics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of General Anxiety Disorder Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 General Anxiety Disorder Therapeutics Market Dynamics
        1.4.1 General Anxiety Disorder Therapeutics Industry Trends
        1.4.2 General Anxiety Disorder Therapeutics Market Drivers
        1.4.3 General Anxiety Disorder Therapeutics Market Challenges
        1.4.4 General Anxiety Disorder Therapeutics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 General Anxiety Disorder Therapeutics by Type
    2.1 General Anxiety Disorder Therapeutics Market Segment by Type
        2.1.1 Itriglumide
        2.1.2 Tedatioxetine
        2.1.3 EDG-004
        2.1.4 Others
    2.2 Global General Anxiety Disorder Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.3 Global General Anxiety Disorder Therapeutics Market Size by Type (2017-2028)
    2.4 United States General Anxiety Disorder Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.5 United States General Anxiety Disorder Therapeutics Market Size by Type (2017-2028)
3 General Anxiety Disorder Therapeutics by Application
    3.1 General Anxiety Disorder Therapeutics Market Segment by Application
        3.1.1 Clinic
        3.1.2 Hospital
        3.1.3 Others
    3.2 Global General Anxiety Disorder Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.3 Global General Anxiety Disorder Therapeutics Market Size by Application (2017-2028)
    3.4 United States General Anxiety Disorder Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.5 United States General Anxiety Disorder Therapeutics Market Size by Application (2017-2028)
4 Global General Anxiety Disorder Therapeutics Competitor Landscape by Company
    4.1 Global General Anxiety Disorder Therapeutics Market Size by Company
        4.1.1 Top Global General Anxiety Disorder Therapeutics Companies Ranked by Revenue (2021)
        4.1.2 Global General Anxiety Disorder Therapeutics Revenue by Player (2017-2022)
    4.2 Global General Anxiety Disorder Therapeutics Concentration Ratio (CR)
        4.2.1 General Anxiety Disorder Therapeutics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of General Anxiety Disorder Therapeutics in 2021
        4.2.3 Global General Anxiety Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global General Anxiety Disorder Therapeutics Headquarters, Revenue in General Anxiety Disorder Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global General Anxiety Disorder Therapeutics Headquarters and Area Served
        4.3.2 Global General Anxiety Disorder Therapeutics Companies Revenue in General Anxiety Disorder Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into General Anxiety Disorder Therapeutics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States General Anxiety Disorder Therapeutics Market Size by Company
        4.5.1 Top General Anxiety Disorder Therapeutics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States General Anxiety Disorder Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global General Anxiety Disorder Therapeutics Market Size by Region
    5.1 Global General Anxiety Disorder Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global General Anxiety Disorder Therapeutics Market Size by Region (2017-2028)
        5.2.1 Global General Anxiety Disorder Therapeutics Market Size by Region: 2017-2022
        5.2.2 Global General Anxiety Disorder Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America General Anxiety Disorder Therapeutics Market Size YoY Growth 2017-2028
        6.1.2 North America General Anxiety Disorder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific General Anxiety Disorder Therapeutics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific General Anxiety Disorder Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe General Anxiety Disorder Therapeutics Market Size YoY Growth 2017-2028
        6.3.2 Europe General Anxiety Disorder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America General Anxiety Disorder Therapeutics Market Size YoY Growth 2017-2028
        6.4.2 Latin America General Anxiety Disorder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa General Anxiety Disorder Therapeutics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa General Anxiety Disorder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Bionomics Limited
        7.1.1 Bionomics Limited Company Details
        7.1.2 Bionomics Limited Business Overview
        7.1.3 Bionomics Limited General Anxiety Disorder Therapeutics Introduction
        7.1.4 Bionomics Limited Revenue in General Anxiety Disorder Therapeutics Business (2017-2022)
        7.1.5 Bionomics Limited Recent Development
    7.2 Edgemont Pharmaceuticals, LLC
        7.2.1 Edgemont Pharmaceuticals, LLC Company Details
        7.2.2 Edgemont Pharmaceuticals, LLC Business Overview
        7.2.3 Edgemont Pharmaceuticals, LLC General Anxiety Disorder Therapeutics Introduction
        7.2.4 Edgemont Pharmaceuticals, LLC Revenue in General Anxiety Disorder Therapeutics Business (2017-2022)
        7.2.5 Edgemont Pharmaceuticals, LLC Recent Development
    7.3 H. Lundbeck A/S
        7.3.1 H. Lundbeck A/S Company Details
        7.3.2 H. Lundbeck A/S Business Overview
        7.3.3 H. Lundbeck A/S General Anxiety Disorder Therapeutics Introduction
        7.3.4 H. Lundbeck A/S Revenue in General Anxiety Disorder Therapeutics Business (2017-2022)
        7.3.5 H. Lundbeck A/S Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. General Anxiety Disorder Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. General Anxiety Disorder Therapeutics Market Trends
    Table 3. General Anxiety Disorder Therapeutics Market Drivers
    Table 4. General Anxiety Disorder Therapeutics Market Challenges
    Table 5. General Anxiety Disorder Therapeutics Market Restraints
    Table 6. Global General Anxiety Disorder Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States General Anxiety Disorder Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global General Anxiety Disorder Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States General Anxiety Disorder Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top General Anxiety Disorder Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global General Anxiety Disorder Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global General Anxiety Disorder Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global General Anxiety Disorder Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global General Anxiety Disorder Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anxiety Disorder Therapeutics as of 2021)
    Table 15. Top Players of General Anxiety Disorder Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in General Anxiety Disorder Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into General Anxiety Disorder Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top General Anxiety Disorder Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States General Anxiety Disorder Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States General Anxiety Disorder Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global General Anxiety Disorder Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global General Anxiety Disorder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global General Anxiety Disorder Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America General Anxiety Disorder Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific General Anxiety Disorder Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe General Anxiety Disorder Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa General Anxiety Disorder Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa General Anxiety Disorder Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Bionomics Limited Company Details
    Table 31. Bionomics Limited Business Overview
    Table 32. Bionomics Limited General Anxiety Disorder Therapeutics Product
    Table 33. Bionomics Limited Revenue in General Anxiety Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. Bionomics Limited Recent Development
    Table 35. Edgemont Pharmaceuticals, LLC Company Details
    Table 36. Edgemont Pharmaceuticals, LLC Business Overview
    Table 37. Edgemont Pharmaceuticals, LLC General Anxiety Disorder Therapeutics Product
    Table 38. Edgemont Pharmaceuticals, LLC Revenue in General Anxiety Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. Edgemont Pharmaceuticals, LLC Recent Development
    Table 40. H. Lundbeck A/S Company Details
    Table 41. H. Lundbeck A/S Business Overview
    Table 42. H. Lundbeck A/S General Anxiety Disorder Therapeutics Product
    Table 43. H. Lundbeck A/S Revenue in General Anxiety Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. H. Lundbeck A/S Recent Development
    Table 45. Research Programs/Design for This Report
    Table 46. Key Data Information from Secondary Sources
    Table 47. Key Data Information from Primary Sources
List of Figures
    Figure 1. General Anxiety Disorder Therapeutics Product Picture
    Figure 2. Global General Anxiety Disorder Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global General Anxiety Disorder Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States General Anxiety Disorder Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States General Anxiety Disorder Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States General Anxiety Disorder Therapeutics Market Share in Global 2017-2028
    Figure 7. General Anxiety Disorder Therapeutics Report Years Considered
    Figure 8. Product Picture of Itriglumide
    Figure 9. Product Picture of Tedatioxetine
    Figure 10. Product Picture of EDG-004
    Figure 11. Product Picture of Others
    Figure 12. Global General Anxiety Disorder Therapeutics Market Share by Type in 2022 & 2028
    Figure 13. Global General Anxiety Disorder Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global General Anxiety Disorder Therapeutics Market Share by Type (2017-2028)
    Figure 15. United States General Anxiety Disorder Therapeutics Market Share by Type in 2022 & 2028
    Figure 16. United States General Anxiety Disorder Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States General Anxiety Disorder Therapeutics Market Share by Type (2017-2028)
    Figure 18. Product Picture of Clinic
    Figure 19. Product Picture of Hospital
    Figure 20. Product Picture of Others
    Figure 21. Global General Anxiety Disorder Therapeutics Market Share by Application in 2022 & 2028
    Figure 22. Global General Anxiety Disorder Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global General Anxiety Disorder Therapeutics Market Share by Application (2017-2028)
    Figure 24. United States General Anxiety Disorder Therapeutics Market Share by Application in 2022 & 2028
    Figure 25. United States General Anxiety Disorder Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States General Anxiety Disorder Therapeutics Market Share by Application (2017-2028)
    Figure 27. North America General Anxiety Disorder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe General Anxiety Disorder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific General Anxiety Disorder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America General Anxiety Disorder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa General Anxiety Disorder Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E General Anxiety Disorder Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Bionomics Limited Revenue Growth Rate in General Anxiety Disorder Therapeutics Business (2017-2022)
    Figure 56. Edgemont Pharmaceuticals, LLC Revenue Growth Rate in General Anxiety Disorder Therapeutics Business (2017-2022)
    Figure 57. H. Lundbeck A/S Revenue Growth Rate in General Anxiety Disorder Therapeutics Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bionomics Limited
Edgemont Pharmaceuticals, LLC
H. Lundbeck A/S
Frequently Asked Questions
General Anxiety Disorder Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
General Anxiety Disorder Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
General Anxiety Disorder Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports